Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.63Price to Sales
VS
Market
Sector
Industry
History
$ 4.72Close
$ 2.07 - $ 7.08 52-Week Range
Ticker Information
Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQEVOKE PHARMA INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EVOK - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 8.01M | 0.63 | $ 12.79M |
| 3/31/2025 | $ 4.69M | 0.4 | $ 11.59M |
| 12/31/2024 | $ 5.74M | 0.56 | $ 10.25M |
| 9/30/2024 | $ 8.4M | 0.97 | $ 8.62M |
| 6/30/2024 | $ 4.22M | 0.56 | $ 7.53M |
| 3/31/2024 | $ 4.04M | 0.66 | $ 6.11M |
| 12/31/2023 | $ 5.72M | 1.1 | $ 5.18M |
| 9/30/2023 | $ 4.28M | 0.99 | $ 4.3M |
| 6/30/2023 | $ 4.71M | 1.32 | $ 3.57M |
| 3/31/2023 | $ 6.44M | 2.22 | $ 2.9M |
Key Performance Insights, Last 5 Years
- EVOKE PHARMA INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, EVOKE PHARMA INC's average P/S has been 261.48.
- The median P/S for EVOKE PHARMA INC during this period was 2.22
- EVOKE PHARMA INC reached its highest P/S over the past 5 years at 4.36K.
- The lowest P/S recorded by EVOKE PHARMA INC in the same timeframe 0.4
EVOKE PHARMA INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for EVOKE PHARMA INC is calculated as follows: Market Cap [ $ 86.3M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] EVOK - Price to Sales, Last 5 years
0.4
Minimum
Mar 31, 2025
4.36K
Maximum
Dec 31, 2020
261.48
Average
2.22
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |